Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Hofseth Biocare Asa has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 distinct examiners and 2 distinct art units, indicating that the prosecution record is divided across separate examination channels. Counsel should track the matters independently and assess whether their technical issues or response strategies can be coordinated.
BOECKELMAN, JACOB A is the busiest examiner, with 1 pending matter. That examiner handles part of the pending record, while another examiner and art unit handle the remaining matter. A portfolio-level review should preserve consistency where appropriate but keep each biotechnology and pharmaceutical response tailored to its own examination record.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
| HIBBERT, CATHERINE S | 1 | 58.8% | +48.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18415498 | RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS | BOECKELMAN, JACOB A | 22d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18415498 | RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS | BOECKELMAN, JACOB A | 22d |
| 18036382 | RESPIRATORY TREATMENTS | HIBBERT, CATHERINE S | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18415498 | RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS | BOECKELMAN, JACOB A | 1655 | §103§112 | Non-Final OA | 22d | Pending | Jan 17, 2024 |
| 18036382 | RESPIRATORY TREATMENTS | HIBBERT, CATHERINE S | 1658 | §102§112DP | Non-Final OA | — | Pending | May 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHofseth Biocare Asa has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Jacob A Boeckelman has the most, with 1 of Hofseth Biocare Asa's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
